143 related articles for article (PubMed ID: 11078160)
1. Peripheral neuropathy associated with anti-GM2 ganglioside antibodies: clinical and immunopathological studies.
O'Hanlon GM; Veitch J; Gallardo E; Illa I; Chancellor AM; Willison HJ
Autoimmunity; 2000 Sep; 32(2):133-44. PubMed ID: 11078160
[TBL] [Abstract][Full Text] [Related]
2. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
3. Anti-GM(2) IgM antibody-induced complement-mediated cytotoxicity in patients with dysimmune neuropathies.
Cavanna B; Jiang H; Allaria S; Carpo M; Scarlato G; Nobile-Orazio E
J Neuroimmunol; 2001 Mar; 114(1-2):226-31. PubMed ID: 11240036
[TBL] [Abstract][Full Text] [Related]
4. Anti-GM2 IgM antibodies: clinical correlates and reactivity with a human neuroblastoma cell line.
Cavanna B; Carpo M; Pedotti R; Scarpini E; Meucci N; Allaria S; Scarlato G; Nobile-Orazio E
J Neuroimmunol; 1999 Feb; 94(1-2):157-64. PubMed ID: 10376949
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndrome.
Ang CW; Jacobs BC; Brandenburg AH; Laman JD; van der Meché FG; Osterhaus AD; van Doorn PA
Neurology; 2000 Apr; 54(7):1453-8. PubMed ID: 10751257
[TBL] [Abstract][Full Text] [Related]
6. Serum anti-GM2 and anti-GalNAc-GD1a ganglioside IgG antibodies are biomarkers for immune-mediated polyneuropathies in cats.
Halstead SK; Jackson M; Bianchi E; Rupp S; Granger N; Menchetti M; Galli G; Freeman P; Kaczmarska A; Bhatti SFM; Brocal J; José-López R; Tipold A; Gutierrez Quintana R; Ives EJ; Liatis T; Nessler J; Rusbridge C; Willison HJ; Rupp A
J Peripher Nerv Syst; 2023 Mar; 28(1):32-40. PubMed ID: 36573790
[TBL] [Abstract][Full Text] [Related]
7. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
Shimoya K; Ohnishi A; Hashimoto T; Yuki N
Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to GM2 ganglioside in neurological disorders.
Odaka M; Yuki N
Intern Med; 2003 Mar; 42(3):220-1. PubMed ID: 12705785
[No Abstract] [Full Text] [Related]
10. Novel lacto-ganglio type gangliosides with GM2-epitope in bovine brain which react with IgM from a patient of the amyotrophic lateral sclerosis-like disorder.
Nakao T; Kon K; Ando S; Miyatake T; Yuki N; Li YT; Furuya S; Hirabayashi Y
J Biol Chem; 1993 Oct; 268(28):21028-34. PubMed ID: 7691804
[TBL] [Abstract][Full Text] [Related]
11. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
[TBL] [Abstract][Full Text] [Related]
12. Childhood-onset multifocal motor neuropathy with IgM antibodies to GM2 and GalNac-GD1a.
Maeda H; Ishii R; Kusunoki S; Chiyonobu T
Brain Dev; 2020 Jan; 42(1):88-92. PubMed ID: 31522790
[TBL] [Abstract][Full Text] [Related]
13. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
14. Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a.
Kaida K; Kusunoki S; Kamakura K; Motoyoshi K; Kanazawa I
J Neuroimmunol; 2001 Feb; 113(2):260-7. PubMed ID: 11164910
[TBL] [Abstract][Full Text] [Related]
15. Results of testing for anti-GM1 antibodies.
McCombe PA; Wilson R; Prentice RL
J Clin Neurosci; 2000 May; 7(3):209-12. PubMed ID: 10833617
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to GM1b and GalNAc-GD1a: relationship to Campylobacter jejuni infection and acute motor axonal neuropathy in China.
Yuki N; Ho TW; Tagawa Y; Koga M; Li CY; Hirata K; Griffin JW
J Neurol Sci; 1999 Apr; 164(2):134-8. PubMed ID: 10402024
[TBL] [Abstract][Full Text] [Related]
17. The first total synthesis of ganglioside GalNAc-GD1a, a target molecule for autoantibodies in Guillain-Barré syndrome.
Fujikawa K; Nakashima S; Konishi M; Fuse T; Komura N; Ando T; Ando H; Yuki N; Ishida H; Kiso M
Chemistry; 2011 May; 17(20):5641-51. PubMed ID: 21469228
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of unique gangliosides with GM2-determinant in human uterine cervical carcinoma-derived cell lines.
Tanaka K; Miyazawa M; Mikami M; Aoki D; Kiguchi K; Iwamori M
Glycoconj J; 2016 Oct; 33(5):745-54. PubMed ID: 27270764
[TBL] [Abstract][Full Text] [Related]
19. IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release.
Ortiz N; Rosa R; Gallardo E; Illa I; Tomas J; Aubry J; Sabater M; Santafé M
J Neuroimmunol; 2001 Sep; 119(1):114-23. PubMed ID: 11525808
[TBL] [Abstract][Full Text] [Related]
20. Anti-GM2 antibody positive Guillain-Barré syndrome presenting with ataxia in a pediatric patient: An atypical manifestation.
Deliceo Göbüt E; Us Ö; Işık U
Brain Dev; 2021 Jun; 43(6):729-733. PubMed ID: 33726944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
